V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270019259 | 270010460 | null | 68.4 | null | 2018-01-22 | 2018-01-22 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 270022133 | DACARBAZINE |
| 270019260 | 270010466 | 1.88 | 32 | Disease modification (D) | 2018-12-10 | 2018-12-10 | VINCRISTINE | 2 | N | 270022215 | IGEV R |
| 270019261 | 270014895 | null | 74.9 | Curative (C) | 2015-09-28 | 2016-01-05 | ICE | N | N | 270022247 | CARBOPLATIN + CETUXIMAB + FU |
| 270019262 | 270010476 | 1.63 | 55.2 | Curative (C) | 2014-08-06 | 2014-08-20 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | null | 270022283 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270019263 | 270010483 | 1.72 | 92 | Curative (C) | 2017-01-30 | 2017-01-30 | RATHL TRIAL | 02 | N | 270022352 | LACE |
| 270019264 | 270010516 | 1.7 | 70 | Palliative (P) | 2018-09-25 | 2018-10-11 | CYCLOPHOSPHAMIDE | N | N | 270022895 | ENZALUTAMIDE |
| 270019265 | 270010524 | 1.69 | null | Disease modification (D) | 2014-09-27 | 2015-07-23 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 2 | N | 270022984 | CVP R |
| 270019266 | 270010527 | 1.77 | 88.1 | Curative (C) | 2017-11-11 | 2017-12-09 | LENALIDOMIDE | 02 | N | 270022987 | ESHAP R |
| 270019268 | 270020206 | 1.59 | 45 | Palliative (P) | 2019-01-06 | 2019-01-13 | LENALIDOMIDE | N | N | 270023123 | BLEOMYCIN |
| 270019269 | 270010534 | 1.76 | 67.4 | Curative (C) | 2017-12-10 | 2017-12-10 | Nilotinib | N | N | 270023155 | CVP R |
| 270019270 | 270014923 | null | 76.4 | Palliative (P) | 2015-07-24 | 2016-05-07 | BLEOMYCIN | null | null | 270023156 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE |
| 270019271 | 270014925 | 1.62 | 80 | Palliative (P) | 2018-03-31 | 2018-04-01 | Carboplatin + Etoposide iv&po | N | N | 270023166 | CARBO + FLUOROURACIL |
| 270019272 | 270010561 | 1.64 | 59 | Curative (C) | 2015-08-06 | 2016-10-28 | PEMBROLIZUMAB | N | N | 270023353 | CARBO + FLUOROURACIL |
| 270019273 | 270010568 | 1.62 | 64.4 | Palliative (P) | 2015-06-08 | 2015-07-24 | IBRUTINIB | 02 | N | 270023443 | VINORELBINE |
| 270019274 | 270010573 | 1.62 | 71.2 | Palliative (P) | 2018-05-23 | 2018-05-30 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL | 02 | null | 270023459 | CISPLATIN + ETOPOSIDE |
| 270019275 | 270010592 | 1.73 | 65 | Palliative (P) | 2016-07-12 | 2017-10-13 | CAPECITABINE + CARBOPLATIN | N | N | 270023690 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019276 | 270018547 | null | 57 | Disease modification (D) | 2017-06-23 | 2017-07-04 | BENDAMUSTINE + CYTARABINE + RITUXIMAB | N | N | 270023710 | RUXOLITINIB |
| 270019277 | 270010610 | 1.73 | 76.1 | Disease modification (D) | 2017-07-31 | 2017-12-10 | CARBOPLATIN + RT | N | N | 270024025 | IRINOTECAN + MDG + PANITUMUMAB |
| 270019278 | 270010622 | 1.61 | 80 | Palliative (P) | 2016-06-18 | 2016-06-19 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 270024192 | CARBOPLATIN + RT |
| 270019279 | 270010627 | 1.67 | null | Palliative (P) | 2017-04-02 | 2017-04-02 | Paclitaxel 7 day | N | N | 270024216 | CARBOPLATIN + RT |
| 270019280 | 270017252 | null | null | null | 2017-10-19 | 2017-10-19 | Docetaxel | N | N | 270024270 | BLEOMYCIN |
| 270019281 | 270010642 | null | 59 | Palliative (P) | 2018-06-18 | 2018-06-18 | CAM-PLEX Trial | N | N | 270024510 | FLUOROURACIL + IRINOTECAN + OXALIPLATIN |
| 270019282 | 270010654 | 1.82 | 70.1 | Curative (C) | 2016-06-08 | 2016-06-14 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 270024614 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270019283 | 270010660 | 1.66 | null | Adjuvant (A) | 2015-11-03 | 2015-11-03 | OXALIPLATIN | 2 | N | 270024741 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270019284 | 270010664 | 1.69 | 54.6 | Palliative (P) | 2018-09-06 | 2018-09-07 | IBRUTINIB | 02 | N | 270024754 | IBRUTINIB |
| 270019285 | 270014981 | 1.62 | 84.9 | Palliative (P) | 2019-04-04 | 2019-04-04 | Raltitrexed | N | N | 270024790 | CARBO + FLUOROURACIL |
| 270019286 | 270010680 | 1.76 | 96.2 | Not known (9) | 2019-07-11 | 2019-08-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 270024883 | AXITINIB |
| 270019287 | 270014986 | 1.84 | null | Curative (C) | 2019-01-10 | 2019-01-24 | IBRUTINIB | 02 | N | 270024893 | IRINOTECAN + MDG + PANITUMUMAB |
| 270019288 | 270010688 | null | 96.5 | Palliative (P) | 2018-06-22 | 2018-06-25 | LENALIDOMIDE | N | N | 270025071 | CARBO + GEMCITABINE + RITUXIMAB |
| 270019289 | 270010694 | 1.89 | 80.3 | Disease modification (D) | 2016-09-12 | 2016-09-12 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | 02 | N | 270025100 | IRINOTECAN + PANITUMUMAB + MDG |
| 270019290 | 270010701 | null | 59.9 | Curative (C) | 2017-03-17 | 2017-03-23 | CARBOPLATIN + RT | 02 | N | 270025137 | FOXTROT TRIAL |
| 270019291 | 270010702 | 1.75 | 31 | Disease modification (D) | 2017-09-29 | 2017-10-06 | Irinotecan + Raltitrexed | 2 | N | 270025142 | CARBOPLATIN + CETUXIMAB + FU |
| 270019292 | 270017279 | 1.66 | 55 | Palliative (P) | 2019-06-07 | 2019-06-13 | CARBOPLATIN + RT | 02 | N | 270025491 | CAPECITABINE + CARBOPLATIN |
| 270019293 | 270010734 | null | null | Disease modification (D) | null | 2018-01-25 | Carboplatin + Cetux + FU (>Cycle 2) | N | N | 270025878 | CARBOPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019294 | 270010749 | 0 | 89.8 | Curative (C) | 2018-05-31 | 2018-06-02 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270001351 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270019295 | 270015017 | 1.8 | 53 | Palliative (P) | 2015-06-18 | 2019-07-14 | Arsenic Trioxide (consolidation) | 2 | N | 270002435 | DACARBAZINE |
| 270019296 | 270015020 | 1.76 | 68.4 | Palliative (P) | 2017-06-12 | 2017-09-19 | CYCLOPHOSPHAMIDE + DACARBAZINE + VINCRISTINE | null | null | 270004490 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270019297 | 270010773 | 1.76 | 91.6 | Curative (C) | 2017-11-19 | 2018-03-05 | Bevacizumab + Capecitabine | N | N | 270004767 | CARBO + FLUOROURACIL |
| 270019298 | 270010777 | 1.47 | 106.7 | Curative (C) | 2019-08-07 | 2019-08-07 | BLEOMYCIN | N | N | 270004923 | CAPECITABINE + CETUXIMAB + IRINOTECAN |
| 270019299 | 270010788 | 1.8 | 64 | Palliative (P) | 2018-03-16 | 2018-03-16 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 270006274 | CARBOPLATIN + CETUXIMAB + FLUOROURACIL |
| 270019300 | 270015037 | null | 92 | Curative (C) | null | 2018-05-16 | FLUOROURACIL + RT | null | null | 270010216 | CAPECITABINE + CARBOPLATIN |
| 270019301 | 270010808 | 1.64 | null | Palliative (P) | null | 2016-04-18 | FOCUS4 TRIAL | null | null | 270010445 | CUFOX TRIAL |
| 270019302 | 270010811 | null | null | Disease modification (D) | 2016-12-13 | 2016-12-26 | SCOT TRIAL | N | N | 270010649 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 270019303 | 270019732 | null | null | Palliative (P) | 2018-04-10 | 2018-05-15 | Cetuximab+Cisplatin+FU (> Cycle 2) | N | null | 270011974 | CARBO + FLUOROURACIL |
| 270019304 | 270010819 | 1.73 | 52.4 | Disease modification (D) | 2017-04-24 | 2017-05-13 | CAP + RT | 02 | N | 270013426 | PACLITAXEL |
| 270019305 | 270019316 | 1.53 | 66 | Palliative (P) | 2017-07-13 | 2018-01-08 | RUXOLITINIB | 02 | N | 270013472 | CYCLOPHOSPHAMIDE + FLUDARABINE |
| 270019306 | 270010827 | 1.65 | 58.1 | null | null | 2018-12-28 | Ralitrexed | N | N | 270014838 | PACLITAXEL |
| 270019307 | 270015050 | 1.57 | 102.9 | Curative (C) | 2017-06-21 | 2017-06-28 | CARBOPLATIN + RT | 2 | null | 270016014 | CAP + RT |
| 270019308 | 270010838 | 1.54 | 88.1 | Disease modification (D) | 2019-10-11 | 2019-10-11 | Docetaxel 75mg/m2 (21 day) | 01 | N | 270017533 | PAZOPANIB |
| 270019309 | 270010843 | null | 102.3 | Palliative (P) | 2018-07-10 | 2018-09-05 | Paclitaxel 80mg/m2 day 1 8 15 | null | N | 270018514 | CARBOPLATIN + ETOPOSIDE |